Business Context and Reporting Period
Company: IDEAYA Biosciences, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: September 30, 2019
Reporting Period: Events occurring on September 30, 2019
The filing reports material definitive agreements and other events related to the Company's corporate headquarters and operational facilities.
Key Financial Metrics
This Form 8-K does not provide financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The filing focuses exclusively on lease agreements and facility changes.
Material Changes
- South San Francisco Lease Expansion: Entered into a Second Amendment to the lease at 7000 Shoreline Court, Suite 350, South San Francisco, CA.
- Expands leased space by approximately 5,500 square feet.
- Includes a right to terminate approximately 4,500 square feet of the new space prior to February 1, 2020, subject to an early termination fee.
- San Diego Lease Termination: Terminated the lease at 3033 Science Park Road, San Diego, CA, effective September 30, 2019.
- Termination is concurrent with the South San Francisco expansion.
- Facilitates the relocation of target identification and validation operations from San Diego to South San Francisco.
Guidance, Outlook, and Risks
Management Commentary: The Company is consolidating operations by relocating specific functions from San Diego to its South San Francisco headquarters. The filing notes that the full terms of the Lease Amendment are qualified by reference to the exhibit filed in the Quarterly Report on Form 10-Q for the period ended September 30, 2019.
Risks and Contingencies: The filing does not explicitly detail financial risks or contingencies beyond the standard lease obligations and the potential early termination fee associated with the South San Francisco expansion.
Investor Verification Checklist
- Verify the specific amount of the early termination fee for the South San Francisco lease in the Form 10-Q exhibit.
- Confirm the total cost impact of the lease expansion versus the savings from the San Diego termination.
- Review the Form 10-Q for the quarter ended September 30, 2019, for detailed financial implications of these facility changes.
- Assess the timeline for the relocation of operations from San Diego to South San Francisco.